BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) was the target of unusually large options trading on Monday. Stock investors acquired 2,478 call options on the stock. This is an increase of approximately 59% compared to the average volume of 1,554 call options. Analyst Ratings Changes Separately, Needham & Company LLC reiterated a “buy” rating […]
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Receives $13 29 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
iShares U S Energy ETF (NYSEARCA:IYE) Hits New 52-Week High at $50 63 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Salesforce (NYSE:CRM – Get Free Report) had its price target increased by research analysts at Canaccord Genuity Group from $290.00 to $350.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the CRM provider’s stock. Canaccord Genuity Group’s target price points to a […]
Salesforce (NYSE:CRM – Get Free Report) had its price objective raised by investment analysts at JPMorgan Chase & Co. from $260.00 to $310.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the CRM provider’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of […]